EL.En. (ELN) Investor Update summary
Event summary combining transcript, slides, and related documents.
Investor Update summary
8 Jul, 2026Transaction overview and rationale
Sale of a 59–59.18% stake in Penta Laser Zhejiang to YOFC for CNY 240 million (approx. EUR 30.5 million), valuing the company at CNY 405 million (approx. EUR 51.5 million), with closing expected within 90 days.
Cutlite Penta remains fully owned by El.En.; it was excluded from the deal due to negative customer reaction and governance concerns, preserving Italian control and brand identity.
Ot-las retains a 19–19.2% stake in Penta Laser Zhejiang, with a lock-up until 2027 and a put option at 1.05x net asset value.
Agreement includes price adjustment clauses and unlimited indemnity for two specific legal and impairment cases.
Divested activities will be excluded from El.En.'s consolidation perimeter after closing.
Financial impact and use of proceeds
PLZ generated €81.8 million revenue and -€7.1 million EBIT in 2024, with a positive net financial position of €9.8 million.
The sale is expected to generate a consolidated gross capital gain of about €6 million, subject to final adjustments.
Sale proceeds will primarily repay financing from El.En. to Ot-las, strengthening the group’s net financial position and supporting future growth investments.
Strategic and operational implications
Collaboration with YOFC is expected to revitalize Penta Laser Zhejiang, leveraging YOFC’s technological expertise.
Italian operations in laser cutting will focus on expanding international presence and maintaining a strong made-in-Italy identity.
No immediate plans for further divestment of the Italian industrial business; strategic alternatives may be considered in the future, excluding Chinese partnerships.
Continued investment in distribution network, with nine direct sales subsidiaries in Europe by end-2025.
Ongoing growth initiatives in marking business and other industrial segments.
Latest events from EL.En.
- Revenue up 5.1% to €285.3M; EBIT and net income down; Chinese unit divested.ELN
Q2 20259 Jul 2026 - Net income rose 5.9% to €27.3M as EBIT fell 12.1% but margins and cash flow remained strong.ELN
H1 20249 Jul 2026 - Medical sector growth drove Q1 revenue and margin gains, offsetting industrial weakness.ELN
Q1 20268 Jul 2026 - Revenue up 4.4% to €591M, net profit down 15.9%, strong cash, positive 2026 outlook.ELN
Q4 20258 Jul 2026 - Q1 2025 revenue up 8.8%, EBIT up 12%, strong growth in all segments, 2025 outlook confirmed.ELN
Q1 202530 Jun 2026 - 2025 revenues set to reach €590.8M, driven by innovation and global expansion.ELN
Investor presentation24 Mar 2026 - Net income up 7% to €51.6M as medical growth offset industrial decline; 2025 outlook cautious.ELN
Q4 202422 Jan 2026 - Q3 2024 delivered higher profits and margins, driven by medical growth and a major divestment.ELN
Q3 202422 Jan 2026 - Majority of the laser cutting division to be sold to YOFC for EUR 55.3M, boosting cash and focus.ELN
Investor Update15 Jan 2026